Key result
Hydralazine and hexamethonium were evaluated for clinical response and safety in patients with hypertension, but quantitative results are not provided in the truncated abstract.
Why the study?
What are the side-effects, safety, best method of administration, and clinical response of hydralazine and hexamethonium in patients with hypertension?
Population
Patients with hypertension, ages 17 to 71 years.
Design
Case_series
Authors
Loading...
Should not change hypertension practice; hypothesis-generating case series leaves optimal use and safety open for controlled trials.
Observational
No
What are the side-effects, safety, best method of administration, and clinical response of hydralazine and hexamethonium in patients with hypertension?
This case series evaluates the clinical use, safety, and administration of hydralazine and hexamethonium for the treatment of hypertension.
Robert R. J. Hilker (1953) conducted an observational in Hypertension. Hydralazine and hexamethonium was evaluated. Hydralazine and hexamethonium were evaluated for clinical response and safety in patients with hypertension, but quantitative results are not provided in the truncated abstract.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: